Your session is about to expire
← Back to Search
Proactive Panel Management Clinics for HFrEF for Heart Failure (DASH-HF Trial)
N/A
Waitlist Available
Led By Boback Ziaeian, MD PhD
Research Sponsored by VA Greater Los Angeles Healthcare System
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6-months
Awards & highlights
DASH-HF Trial Summary
This trial is testing whether a quality improvement intervention that uses a prospective panel management intervention to optimize medical treatment for Veterans with heart failure with reduced ejection fraction is more effective than usual VA health care services.
Eligible Conditions
- Heart Failure
DASH-HF Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6-months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6-months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Optimization Potential Score
Secondary outcome measures
Change in Total Deaths
Change in Total Hospitalizations
Change in proportion receiving ACE/ARB/ARNI
+4 moreOther outcome measures
Clinician time per patient
Health Service Efficiency
Qualitative analysis of patient satisfaction
DASH-HF Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
Patients with perceived gaps in performance measures for guideline-directed medical therapies for heart failure with reduced ejection fraction will be chart-reviewed and called impromptu to receive point of care medication titration or reintegration into routine heart failure clinic. Patients lost to follow-up may be better identified using the HFrEF panel management tools.
Group II: Usual CareActive Control1 Intervention
A control group of patients with HFrEF will receive routine primary and cardiology care as currently indicated in routine scheduled clinic grids. Patients are at the discretion of their primary care and cardiology clinicians regarding whether further HFrEF optimization is warranted. While panel management data is available to all clinicians, clinical workflows and responsibilities do not encourage the use of panel data or response to performance measurement for HFrEF.
Find a Location
Who is running the clinical trial?
VA Greater Los Angeles Healthcare SystemLead Sponsor
51 Previous Clinical Trials
8,269 Total Patients Enrolled
Boback Ziaeian, MD PhDPrincipal InvestigatorVA Greater Los Angeles Healthcare System
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger